ProQR Therapeutics NV (PRQR)
1.41
-0.06
(-4.08%)
USD |
NASDAQ |
Jun 10, 14:37
ProQR Therapeutics EPS Diluted (Quarterly) : -0.1486 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pharming Group NV | -0.0746 |
| NewAmsterdam Pharma Co. NV | -0.398 |
| Kamada Ltd. | 0.0716 |
| Syndax Pharmaceuticals, Inc. | -0.4835 |
| Opus Genetics, Inc. | -0.7542 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.66M |
| Revenue (Quarterly) | 2.378M |
| Total Expenses (Quarterly) | 18.04M |
| Enterprise Value | 77.22M |
| Gross Profit Margin (Quarterly) | 65.86% |
| Profit Margin (Quarterly) | -658.3% |
| Earnings Yield | -35.64% |
| Normalized Earnings Yield | -35.65 |